Exploring further subtype-specific implications, our analysis reveals that in HR + HER2-BC, where TIL levels are usually low and upfront surgery is common, stiffness could serve as a non-invasive predictor of aggressive tumor behavior. The gene discussed is ERBB2; the disease is neoplasm.